Time-dependent burden of reflux-related endoscopic pathology after sleeve gastrectomy: Clinical value of surveillance endoscopy in a 520-patient cohort
World Journal of Gastrointestinal Surgery · 27.11.2026 · 18 (11)
DOI: 10.4240/wjgs.124213 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Surgery, online erschienen am 27.11.2026. Verfasst von Sinan Aslan und 3 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Sleeve gastrectomy is a widely performed procedure; however, postoperative gastroesophageal reflux disease (GERD) and reflux-related mucosal injury remain clinically persistent concerns. The value and timing of postoperative surveillance endoscopy are controversial, particularly because symptoms may not fully reflect mucosal pathology. AIM To evaluate time-dependent, reflux-related, clinical and endoscopic pathology after sleeve gastrectomy and to assess the clinical utility of postoperative surveillance endoscopy. METHODS This retrospective cohort study included adults who underwent sleeve gastrectomy and both pre- and postoperative upper gastrointestinal endoscopy. Among 560 patients screened, 520 were included in the final cohort; after excluding those with preoperative Barrett’s, 502 were eligible for de novo Barrett’s esophagus analysis. The primary endpoint was strict clinically significant postoperative endoscopic pathology, defined as Los Angeles grade B (LA-B) or higher erosive esophagitis, histology-confirmed Barrett’s, de novo Barrett’s, or esophageal stricture. A broader clinically actionable endpoint was analyzed separately. RESULTS The mean follow-up was 52.8 ± 20.9 months. GERD symptoms increased from 26.5% to 43.3%, proton pump inhibitor use increased from 22.5% to 50.6%, erosive esophagitis increased from 16.0% to 29.6%, LA-B or higher esophagitis increased from 5.8% to 13.1%, and Barrett’s increased from 3.5% to 10.0%. De novo Barrett’s esophagus occurred in 34/502 (6.8%) patients. Strict clinically significant pathology was present in 108/520 (20.8%) patients, and broader clinically actionable pathology was present in 198/520 (38.1%). Treatment changes occurred in 172/520 (33.1%) patients. CONCLUSION Reflux-related clinical/endoscopic findings increase after sleeve gastrectomy, especially at longer follow-up intervals, thus supporting risk-adapted endoscopic surveillance, particularly beyond 3-5 years, but do not establish requirements for annual endoscopy.
Zitieren
APA
Aslan, S., Soyer, H. V., Adiguzel, M. H., & Sayar, S. (2026). Time-dependent burden of reflux-related endoscopic pathology after sleeve gastrectomy: Clinical value of surveillance endoscopy in a 520-patient cohort. World Journal of Gastrointestinal Surgery, 18(11). https://doi.org/10.4240/wjgs.124213
Vancouver
Aslan S, Soyer HV, Adiguzel MH, Sayar S. Time-dependent burden of reflux-related endoscopic pathology after sleeve gastrectomy: Clinical value of surveillance endoscopy in a 520-patient cohort. World Journal of Gastrointestinal Surgery. 2026;18(11). doi:10.4240/wjgs.124213
BibTeX
@article{Aslan2026,
author = {Aslan, Sinan and Soyer, Hacı Vural and Adiguzel, Mehmet Hatip and Sayar, Samed},
title = {Time-dependent burden of reflux-related endoscopic pathology after sleeve gastrectomy: Clinical value of surveillance endoscopy in a 520-patient cohort},
journal = {World Journal of Gastrointestinal Surgery},
year = {2026},
volume = {18},
number = {11},
doi = {10.4240/wjgs.124213}
}
EUVIMED